PharmTeX: A LaTeX-based Open-source Platform for Automated Reporting Workflow Publication PharmTeX: A LaTeX-based Open-source Platform for Automated Reporting Workflow Certara2018年5月1日
Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Publication Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Certara2018年5月1日
Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Publication Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Certara2018年4月25日
Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…Certara2018年4月13日
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Certara2018年4月9日
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Certara2018年4月1日
Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Publication Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Certara2018年4月1日
Changing the Game in Drug Development Brochure 医薬品開発の大変革 At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…Certara2018年3月19日
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…Certara2018年3月16日
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Certara2018年3月15日